Beta-lactamase inhibitor compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 12, 2016
Grant Date -
Mar 12, 2015
app pub date -
Apr 2, 2013
filing date -
Apr 2, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia):
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully